SCHEMBL26434985

SCHEMBL26434985

c1ccc2c(c1)ccc1cccc(-c3nc(-c4cccc5c4oc4ccccc45)nc(-c4cccc5c4sc4ccccc45)n3)c12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 9/20 0.39
PIK3CD O00329 3/20 0.39
PIK3CB P42338 3/20 0.39
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
BRD4 O60885 1/20 0.36
PIK3CA P42336 1/20 0.36
MTOR P42345 1/20 0.36
PIK3CG P48736 1/20 0.36
KCNH2 Q12809 1/20 0.36
BRDT Q58F21 1/20 0.36
ALOX5 P09917 3/20 0.36
PARP14 Q460N5 1/20 0.33
KDM4E B2RXH2 2/20 0.33
ALDH1A1 P00352 2/20 0.33
MAPT P10636 2/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
ESR1 P03372 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26435029 0.94 ALOX5 (0.40) PRKDCPIK3CDPIK3CBTDP1L3MBTL1
SCHEMBL26435487 0.91 ALOX5 (0.38) PRKDCPIK3CDPIK3CBTDP1L3MBTL1
SCHEMBL26435128 0.91 ALOX5 (0.40) PRKDCPIK3CDPIK3CBTDP1L3MBTL1
SCHEMBL13528942 0.91 PRKDC (0.45) PRKDCPIK3CDPIK3CBBRD4PIK3CA
SCHEMBL12996603 0.91 PRKDC (0.45) PRKDCPIK3CDPIK3CBBRD4PIK3CA
SCHEMBL26435292 0.90 L3MBTL1 (0.41) PRKDCPIK3CDPIK3CBTDP1L3MBTL1
SCHEMBL26435627 0.89 ALOX5 (0.40) PRKDCPIK3CDPIK3CBTDP1L3MBTL1
SCHEMBL26435134 0.89 ALOX5 (0.38) PRKDCPIK3CDPIK3CBTDP1L3MBTL1
SCHEMBL26434986 0.89 ALOX5 (0.37) PRKDCPIK3CDPIK3CBTDP1L3MBTL1
SCHEMBL26435298 0.87 ALOX5 (0.43) PRKDCPIK3CDPIK3CBL3MBTL1BRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS NOM1, MNS1, NOS1 PRKDC 3142/4885PIK3CD 3827/4885PIK3CB 4203/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.